Suzanne Gagnon's most recent trade in Panbela Therapeutics Inc. was a trade of 35,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 30, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Panbela Therapeutics Inc. | Suzanne Gagnon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 35,000 | 35,000 | - | - | Employee Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | Suzanne Gagnon | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2021 | 7,142 | 1,000 (0%) | 0% | 0 | Common Stock | |
| Panbela Therapeutics Inc. | Suzanne Gagnon | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2021 | 3,284 | 46,284 (0%) | 0% | 0 | Common Stock | |
| Panbela Therapeutics Inc. | Suzanne Gagnon | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jan 2021 | 1,000 | 0 (0%) | 0% | 0 | Common Stock |